Tech • AI • Robotics
They Just Made a Chip With Living Human Brain Cells
5/10TL;DR
Human brain organoids and neuron cultures are moving from disease models to experimental computing platforms, raising new hopes for drug discovery and new questions about consciousness and ethics.
KEY POINTS
From skin cells to brain tissue
Researchers can reprogram adult cells from skin, blood, hair or teeth into induced pluripotent stem cells, then grow organ-like tissues including brain organoids. These tiny structures are typically only a few millimeters wide, yet they can contain about 5 million cells, including roughly 2.5 million neurons, allowing scientists to observe early human neural development directly.
Brain waves that resemble early development
When maintained at about 98.6°F for eight months, some human brain organoids produce repetitive electrical oscillations resembling patterns seen in premature infants. That has intensified debate over what such tissue represents: a useful biological model, a primitive neural network, or an early form of organized brain activity still far from anything like a person.
UC San Diego’s organoid work
At UC San Diego, developmental biologist Alysson Muotri grows organoids by the tens of thousands. His lab has used them to study autism, including tissue derived from autistic donors, and has also explored more unusual projects such as Neanderthal-like organoids, exposure experiments tied to space radiation, and systems in which organoids interact with electrodes and robotic devices.
Neurons appear driven to connect
A recurring observation in these labs is that neurons spontaneously seek links to surfaces, electrodes and one another. Researchers report that after electrical stimulation, organoids can show signs of response, memory and anticipation. Supporters see that as evidence that living neural tissue can be programmed; critics say those behaviors should not be confused with consciousness.
Computing with living neurons
In Melbourne, Cortical Labs has built biological computing devices called CL1, each roughly toaster-sized and designed to keep up to 1 million neurons alive for about six months. The company argues that neurons offer qualities conventional hardware lacks, including adaptability, self-repair, resilience and extremely low energy use.
Pong, Doom and reinforcement signals
In a widely discussed 2022 experiment, neuron cultures on microchips were trained to play Pong by receiving predictable electrical pulses for effective behavior and chaotic signals for errors. The cultures improved over time, and the system now offers Pong in cloud sessions while experiments have expanded to Doom. The work is presented as a way to test how biological systems learn by minimizing unpredictability.
Ethics remain unsettled
Most researchers reject claims that current organoids are conscious, but ethicists argue that the field lacks clear thresholds for sentience or moral status. Because organoids are neither recognized as people nor protected like animals under many rules, they occupy a permissive regulatory space. Debate has focused on whether consciousness would require sensory input, a body, a brain stem, a certain size, or some other biological feature.
A size barrier is starting to fall
Organoids usually stop growing at about 5 millimeters because they lack blood vessels and develop oxygen-starved cores. Teams at Johns Hopkins and elsewhere are working on artificial arteries, vascular-like support systems and perfusion methods to push them further. Muotri has reportedly kept organoids alive for three years, while other researchers are aiming for 1 centimeter structures closer to mouse-brain scale.
Drug testing is still the main business
Despite excitement around “organoid intelligence,” most labs still rely on organoids for toxicology and pharmaceutical screening. The rationale is blunt: neuropsychiatric drugs fail about 95% of the time in human trials, in part because animal models often do not reflect human brain biology well enough. In a six-well plate, researchers can produce up to 4,000 organoids, far beyond what is practical with primates.
Policy and funding are shifting
Momentum increased in 2025 when the NIH said it would stop funding research that relies exclusively on animal testing and encouraged alternative models. Later that year, it committed $87 million to a standardized organoid modeling center. Because organoids can be derived from consenting adults rather than embryos, they avoid some older stem-cell controversies while also sidestepping much animal-rights opposition.
CONCLUSION
Human organoids are becoming both a powerful laboratory model and a possible computing substrate. Their scientific value is rising quickly, but the closer they move toward complex learning, the harder it becomes to separate useful tissue from morally significant mind.
Explain this